Payment overview · 2025
General Payments
$17.74
1 reported records · 1 companies
Healthcare provider profile · identity verified
Anthony Jerome Nix, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · SYLACAUGA, AL · NPI 1770874695
Verified facts
What the public records show
CMS Open Payments records show Anthony Jerome Nix, M.D. received $17.74 in general payments during 2025 across 1 reported records.
PFIZER INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 290 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $17.74 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.74 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $17.74 | 1 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $17.74 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
290 | 37 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1091 | 311 |
| Amlodipine Besylate | Amlodipine Besylate | 938 | 258 |
| Gabapentin | Gabapentin | 717 | 127 |
| Levothyroxine Sodium | Levothyroxine Sodium | 611 | 142 |
| Pantoprazole Sodium | Pantoprazole Sodium | 540 | 144 |
| Hydrochlorothiazide | Hydrochlorothiazide | 467 | 139 |
| Lisinopril | Lisinopril | 462 | 116 |
| Omeprazole | Omeprazole | 450 | 136 |
| Carvedilol | Carvedilol | 438 | 106 |
| Glipizide Er | Glipizide | 418 | 104 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 407 | 129 |
| Famotidine | Famotidine | 378 | 66 |
| Ozempic | Semaglutide | 359 | 56 |
| Metformin Hcl Er | Metformin Hcl | 346 | 95 |
| Losartan Potassium | Losartan Potassium | 334 | 101 |
| Potassium Chloride | Potassium Chloride | 316 | 70 |
| Allopurinol | Allopurinol | 315 | 80 |
| Metformin Hcl | Metformin Hcl | 301 | 97 |
| Eliquis | Apixaban | 290 | 37 |
| Trazodone Hcl | Trazodone Hcl | 281 | 53 |
| Mounjaro | Tirzepatide | 277 | 40 |
| Furosemide | Furosemide | 246 | 77 |
| Metoprolol Succinate | Metoprolol Succinate | 240 | 76 |
| Pravastatin Sodium | Pravastatin Sodium | 236 | 70 |
| Tizanidine Hcl | Tizanidine Hcl | 233 | 59 |
| Duloxetine Hcl | Duloxetine Hcl | 229 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 225 | 69 |
| Metoprolol Tartrate | Metoprolol Tartrate | 216 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 205 | 64 |
| Tramadol Hcl | Tramadol Hcl | 204 | 42 |
| Celecoxib | Celecoxib | 203 | 43 |
| Donepezil Hcl | Donepezil Hcl | 199 | 30 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 191 | 58 |
| Ezetimibe | Ezetimibe | 190 | 58 |
| Pregabalin | Pregabalin | 190 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 186 | 57 |
| Meloxicam | Meloxicam | 186 | 56 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 181 | 51 |
| Zolpidem Tartrate | Zolpidem Tartrate | 180 | 32 |
| Montelukast Sodium | Montelukast Sodium | 175 | 46 |
| Simvastatin | Simvastatin | 171 | 50 |
| Citalopram Hbr | Citalopram Hydrobromide | 167 | 51 |
| Escitalopram Oxalate | Escitalopram Oxalate | 159 | 28 |
| Januvia | Sitagliptin Phosphate | 157 | 25 |
| Jardiance | Empagliflozin | 153 | 36 |
| Hydralazine Hcl | Hydralazine Hcl | 143 | 45 |
| Entresto | Sacubitril/Valsartan | 142 | suppressed |
| Glipizide | Glipizide | 127 | 31 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 126 | 25 |
| Ropinirole Hcl | Ropinirole Hcl | 124 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 121 | 34 |
| Alendronate Sodium | Alendronate Sodium | 117 | 33 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 117 | 39 |
| Prednisone | Prednisone | 117 | 80 |
| Clonazepam | Clonazepam | 116 | 20 |
| Memantine Hcl | Memantine Hcl | 108 | 18 |
| Xarelto | Rivaroxaban | 102 | 12 |
| Sertraline Hcl | Sertraline Hcl | 99 | 33 |
| Amitriptyline Hcl | Amitriptyline Hcl | 98 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 94 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 92 | 20 |
| Spironolactone | Spironolactone | 92 | 25 |
| Methocarbamol | Methocarbamol | 88 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 83 | 19 |
| Alprazolam | Alprazolam | 81 | 12 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 80 | 25 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 77 | 14 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 77 | 24 |
| Sucralfate | Sucralfate | 76 | 25 |
| Chlorthalidone | Chlorthalidone | 75 | 25 |
| Meclizine Hcl | Meclizine Hcl | 74 | 39 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 74 | 21 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 72 | 20 |
| Breo Ellipta | Fluticasone/Vilanterol | 68 | 18 |
| Tresiba Flextouch U-200 | Insulin Degludec | 63 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 62 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 61 | 20 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 60 | 22 |
| Benazepril Hcl | Benazepril Hcl | 59 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 59 | 19 |
| Temazepam | Temazepam | 59 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 58 | 28 |
| Fenofibrate | Fenofibrate | 57 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 56 | 42 |
| Atenolol | Atenolol | 54 | 15 |
| Digoxin | Digoxin | 54 | suppressed |
| Glimepiride | Glimepiride | 54 | 14 |
| Telmisartan | Telmisartan | 51 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 48 | 15 |
| Buspirone Hcl | Buspirone Hcl | 47 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 44 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 44 | 17 |
| Ibuprofen | Ibuprofen | 44 | 12 |
| Linzess | Linaclotide | 42 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 40 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 35 | 33 |
| Farxiga | Dapagliflozin Propanediol | 35 | 11 |
| Lorazepam | Lorazepam | 35 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 34 | suppressed |
| Synthroid | Levothyroxine Sodium | 34 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 33 | suppressed |
| Azithromycin | Azithromycin | 33 | 31 |
| Ramipril | Ramipril | 33 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 33 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 24 |
| Dicyclomine Hcl | Dicyclomine Hcl | 32 | 12 |
| Ibandronate Sodium | Ibandronate Sodium | 32 | 17 |
| Levofloxacin | Levofloxacin | 31 | 28 |
| Trulicity | Dulaglutide | 31 | suppressed |
| Fluconazole | Fluconazole | 30 | 25 |
| Sildenafil Citrate | Sildenafil Citrate | 30 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 29 | 11 |
| Clonidine Hcl | Clonidine Hcl | 28 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 28 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 27 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 25 |
| Dexlansoprazole Dr | Dexlansoprazole | 25 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 25 | suppressed |
| Ondansetron Odt | Ondansetron | 25 | 16 |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Nystatin | Nystatin | 23 | 17 |
| Warfarin Sodium | Warfarin Sodium | 23 | suppressed |
| Ketoconazole | Ketoconazole | 22 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Primidone | Primidone | 21 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 20 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 20 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 20 | suppressed |
| Indapamide | Indapamide | 19 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 18 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 18 |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 17 | suppressed |
| Febuxostat | Febuxostat | 17 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Torsemide | Torsemide | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Methylprednisolone | Methylprednisolone | 15 | 14 |
| Metronidazole | Metronidazole | 15 | 15 |
| Rizatriptan | Rizatriptan Benzoate | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Carbamazepine | Carbamazepine | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 14 |
| Indomethacin | Indomethacin | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Cefdinir | Cefdinir | 13 | 13 |
| Diclofenac Sodium Er | Diclofenac Sodium | 13 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Klor-Con 10 | Potassium Chloride | 13 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 13 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 12 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 12 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Mirtazapine | Mirtazapine | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
| Zonisamide | Zonisamide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.74 · 1 records | PFIZER INC. | NURTEC ODT, PAXLOVID | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error